Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 3721 AL 3735

The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases

Liu H, Xu S, Wang C, Deng Y, Xu B, Yang T, Sun J, Liu W.

Neuroscience. 2022 Nov 10;504:79-92. doi: 10.1016/j.neuroscience.2022.09.021. Epub 2022 Oct 3.

Neuroprotective potential of Moringa oleifera mediated by NF-kB/Nrf2/HO-1 signaling pathway: A review

Mundkar M, Bijalwan A, Soni D, Kumar P.

J Food Biochem. 2022 Dec;46(12):e14451. doi: 10.1111/jfbc.14451. Epub 2022 Oct 7.

Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases

Li RL, Wang LY, Duan HX, Zhang Q, Guo X, Wu C, Peng W.

Front Pharmacol. 2022 Sep 22;13:937289. doi: 10.3389/fphar.2022.937289. eCollection 2022.

Cytoskeletal dysregulation and neurodegenerative disease: Formation, monitoring, and inhibition of cofilin-actin rods

Wurz AI, Schulz AM, O'Bryant CT, Sharp JF, Hughes RM.

Front Cell Neurosci. 2022 Sep 22;16:982074. doi: 10.3389/fncel.2022.982074. eCollection 2022.

Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1

van der Bent ML, Evers MM, Vallès A.

Biologics. 2022 Sep 30;16:141-160. doi: 10.2147/BTT.S270657. eCollection 2022.

Recent Updates on the Development of Deuterium-Containing Drugs for the Treatment of Cancer

Belete TM.

Drug Des Devel Ther. 2022 Oct 4;16:3465-3472. doi: 10.2147/DDDT.S379496. eCollection 2022.

Chorea

Stimming EF, Bega D.

Continuum (Minneap Minn). 2022 Oct 1;28(5):1379-1408. doi: 10.1212/CON.0000000000001169.

Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis

Tortorella I, Argentati C, Emiliani C, Morena F, Martino S.

Cells. 2022 Oct 1;11(19):3093. doi: 10.3390/cells11193093.

A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era

Ruscitti F, Origone P, Rosti G, Trevisan L, Marchese R, Brugnolo A, Massa F, Castellini P, Mandich P.

Clin Case Rep. 2022 Oct 6;10(10):e6308. doi: 10.1002/ccr3.6308. eCollection 2022 Oct.

Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases

Zhang L, Liu Y, Lu Y, Wang G.

Biochem Pharmacol. 2022 Dec;206:115295. doi: 10.1016/j.bcp.2022.115295. Epub 2022 Oct 12.

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Frank S, Testa C, Edmondson MC, Goldstein J, Kayson E, Leavitt BR, Oakes D, O'Neill C, Vaughan C, Whaley J, Gross N, Gordon MF, Savola JM; Huntington Study Group/ARC-HD Investigators and Coordinators.

CNS Drugs. 2022 Nov;36(11):1207-1216. doi: 10.1007/s40263-022-00956-8. Epub 2022 Oct 15.

Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases

George M, Tharakan M, Culberson J, Reddy AP, Reddy PH.

Ageing Res Rev. 2022 Dec;82:101756. doi: 10.1016/j.arr.2022.101756. Epub 2022 Oct 13.

Treating GNAO1 mutation-related severe movement disorders with oxcarbazepine: a case report

Ling W, Huang D, Yang F, Yang Z, Liu M, Zhu Q, Huang J, Zhou R, Chen X.

Transl Pediatr. 2022 Sep;11(9):1577-1587. doi: 10.21037/tp-22-297.

Neuroferritinopathy

Chinnery PF.

2005 Apr 25 [updated 2022 Oct 20]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias